A surveillance system to monitor excess mortality of people with mental illness in Canada

Canadian Journal of Psychiatry

Volumn 60, Issue 12, 2015, Pages 571-579

  Lesage, Alain ^a,b   Rochette, Louis ^b   Émond, Valérie ^b   Pelletier, Éric ^b   St Laurent, Danielle ^b   Diallo, Fatoumata Binta ^a   Kisely, Stephen ^c  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE MONTRÉAL   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Mentally ill people; Mortality; Surveillance and system performance indicators

Indexed keywords

ANXIETY DISORDER; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; DEMENTIA; DEPRESSION; DISEASE SURVEILLANCE; ENDOCRINE DISEASE; FACE VALIDITY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL DISEASE; HEALTH INSURANCE; HOSPITAL DISCHARGE; HUMAN; ICD-10; ICD-9; INFECTION; INJURY; LIFE EXPECTANCY; LONGITUDINAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; MENTAL PATIENT; MOOD DISORDER; MORTALITY; NEUROLOGIC DISEASE; PATIENT CARE; PATIENT MONITORING; PREVALENCE; RESPIRATORY TRACT DISEASE; SCHIZOPHRENIA; SEX DIFFERENCE; SUICIDE; ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; CAUSE OF DEATH; CHILD; DEPRESSIVE DISORDER; EPIDEMIOLOGICAL MONITORING; INFANT; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; NEOPLASM; PRESCHOOL CHILD; QUEBEC; REPRODUCIBILITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; CANADA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DEPRESSIVE DISORDER; EPIDEMIOLOGICAL MONITORING; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; LIFE EXPECTANCY; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; MORTALITY; NEOPLASMS; PREVALENCE; QUEBEC; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84949557189     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371506001208     Document Type: Article

References (42)

1. Amaddeo F, Tansella M. Mortality among people with mental disorders. Epidemiol Psichiatr Soc. 2010;19(1):1-3.
2. Lawrence D, Kisely S, Pais J. The epidemiology of excess mortality in people with mental illness. Can J Psychiatry. 2010;55(12):752-760.
3. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123-1131.
4. Tiihonen J, Lonnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620-627.
5. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in western Australia: retrospective analysis of population based registers. BMJ. 2013;346:f2539.
6. Chwastiak LA, Tek C. The unchanging mortality gap for people with schizophrenia. Lancet. 2009;374(9690):590-592.
7. Lawrence DM, Holman CD, Jablensky AV, et al. Death rate from ischaemic heart disease in western Australian psychiatric patients 1980-1998. Br J Psychiatry. 2003;182:31-36.
8. Giddings G. Sense and sensitivity. CMAJ. 2013;185(18):1555.
9. Thornicroft G. A new mental health strategy for England. BMJ. 2011;342:d1346.
10. Mental Health Commission of Canada (MHCC). Changing directions, changing lives: the mental health strategy for Canada. Calgary (AB): MHCC; 2012.
11. Tansella M, Thornicroft G. A conceptual framework for mental health services: the matrix model. Psychol Med. 1998;28(3):503-508.
12. Pelletier C, Dai S, Roberts KC, et al. Report summary. Diabetes in Canada: facts and figures from a public health perspective. Chronic Dis Inj Can. 2012;33(1):53-54.
13. Public Health Agency of Canada (PHAC). Report from the Canadian chronic disease surveillance system: mental illness in Canada. Ottawa (ON): PHAC; 2015.
14. Kisely S, Lin E, Gilbert C, et al. Use of administrative data for the surveillance of mood and anxiety disorders. Aust NZJ Psychiatry. 2009;43(12):1118-1125.
15. Kisely S, Lin E, Lesage A, et al. Use of administrative data for the surveillance of mental disorders in 5 provinces. Can J Psychiatry. 2009;54(8):571-575.
16. Lesage A, Émond V, Rochette L. Surveillance of mental disorders in Québec: prevalence, mortality and service utilization profile. Quebec (QC): Direction de l'analyse et de l'évaluation des systèmes de soins et services, Institut national de santé publique du Québec; 2013.
17. Blais C, Jean S, Sirois C, et al. Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach. Chronic Dis Inj Can. 2014;34(4):226-235.
18. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.
19. Grigoletti L, Perini G, Rossi A, et al. Mortality and cause of death among psychiatric patients: a 20-year case-register study in an area with a community-based system of care. Psychol Med. 2009;39(11):1875-1884.
20. Wahlbeck K, Westman J, Nordentoft M, et al. Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry. 2011;199(6):453-458.
21. Vanasse A, Courteau J, Fleury MJ, et al. Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates. Soc Psychiatry Psychiatr Epidemiol. 2012;47(4):533-543.
22. Chiang CL. The life table and its applications. Original ed. Malabar (FL): RE Krieger; 1984.
23. Hsieh JJ. A general theory of life table construction and a precise abridged life table method. Biom J. 1991;33(2):143-162.
24. Kisely S, Smith M, Lawrence D, et al. Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia. Br J Psychiatry. 2005;187:552-558.
25. Bjorkenstam E, Ljung R, Burstrom B, et al. Quality of medical care and excess mortality in psychiatric patients-a nationwide registerbased study in Sweden. BMJ Open. 2012;2:e000778.
26. Kisely S, Smith M, Lawrence D, et al. Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ. 2007;176(6):779-784.
27. Murphy JM, Gilman SE, Lesage A, et al. Time trends in mortality associated with depression: findings from the Stirling County study. Can J Psychiatry. 2010;55(12):776-783.
28. Schmitz N, Messier L, Nitka D, et al. Factors associated with disability and depressive symptoms among individuals with diabetes: a community study in Quebec. Psychosomatics. 2011;52(2):167-177.
29. Schmitz N, Wang J, Malla A, et al. Joint effect of depression and chronic conditions on disability: results from a population-based study. Psychosom Med. 2007;69(4):332-338.
30. Lesage A, Vasiliadis H, Gagné M, et al. Prevelance of mental illnesses and related service utilization in Canada: an analysis of the Canadian Community Health Survey. Mississauga. (ON): Canadian Collaborative Mental Health Initiative; 2006.
31. Ouadahi Y, Lesage A, Rodrigue J, et al. [Can mental health problems be diagnosed by general physicians? Perspectives of family physicians according to administrative standards]. Sante Ment Que. 2009;34(1):161-172. French.
32. Saha S, Chant D, Welham J, et al. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2(5):e141.
33. Tu K, Wang M, Ivers N, et al. Case definition validation study for mental health surveillance in Canada. Toronto (ON): Institute of Clinical Evaluative Sciences; 2012.
34. West SL, Richter A, Melfi CA, et al. Assessing the Saskatchewan database for outcomes research studies of depression and its treatment. J Clinical Epidemiol. 2000;53(8):823-831.
35. Public Health Agency of Canada (PHAC). Report from the Canadian Chronic Disease Surveillance System: hypertension in Canada. Ottawa (ON): PHAC; 2010.
36. Lesage A, St-Laurent D, Gagne M, et al. [Suicide prevention from a public health perspective]. Sante Ment Que. 2012;37(2):239-255. French.
37. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294(16):2064-2074.
38. Public Health Agency of Canada (PHAC). Report from the National Diabetes Surveillance System: diabetes in Canada, 2009 [Internet]. Ottawa (ON): Chronic Disease Surveillance Division Centre for Chronic Disease Prevention and Control; 2009 [cited 2015 Nov. 6]. Available from: http://www.phac-aspc.gc.ca/publicat/2009/ndssdic-snsddac-09/index-eng.php.
39. Canadian Diabetes Association (CDA). An economic tsunami the cost of diabetes in Canada [Internet] Toronto (ON): CDA; 2009 [cited 2015 Nov. 6]. Available from: http://www.diabetes.ca/publications-newsletters/advocacy-reports/economic-tsunami-the-cost-of-diabetes-in-canada.
40. Rosenberg S, Rosen A. Can mental health commissions really drive reform? Towards better resourcing, services, accountability and stakeholder engagement. Australas Psychiatry. 2012;20(3):193-198.
41. Institute of Health Economics (IHE). Consensus statement on improving mental health transitions [Internet]. Edmonton (AB): IHE; 2014 [cited year 2015 Nov. 6]. Available from: http://www.ihe.ca/advanced-search/consensus-statement-on-improving-mental-health-transitions.
42. Kirby MJL, Keon WJ. Out of the shadows at last. Transforming mental health, mental illness and addiction services in Canada [Internet]. Ottawa (ON): The Standing Senate Committee on Social Affairs, Science and Technology, Parliament of Canada; 2006 [cited 2015 Nov. 6]. Available from: http://www.parl.gc.ca/content/sen/committee/391/soci/rep/rep02may06-e.htm.